Roman Lyman

Title: Innovations in Drug Delivery: The Work of Roman Lyman

Introduction

Roman Lyman is an innovative inventor based in San Francisco, CA. He has made significant contributions to the field of drug delivery through his patented invention. His work focuses on the development of advanced biocompatible devices that enhance the efficacy of drug administration.

Latest Patents

Lyman holds a patent for a groundbreaking invention titled "3D printed microneedles for microencapsulated mammalian cell extrusion." This device features a 3D printed biocompatible drug delivery system that includes a fluid delivery channel with three segments and a receiving chamber equipped with an array of microneedles. The design effectively addresses the challenges of colloidal stability in multi-phase formulations, thereby preventing nozzle blockage. Qualitative screening cytotoxicity tests have demonstrated that the device does not exhibit cytotoxicity, ensuring equivalent viability to control treatments. The biocompatibility results indicate that this innovative design can be applied across various regenerative medicine and drug delivery applications.

Career Highlights

Roman Lyman is affiliated with Santa Clara University, where he continues to advance his research in drug delivery technologies. His work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

Lyman collaborates with notable colleagues, including Cecilia Hemingway and Maryam Mobed-Miremadi, who contribute to the research and development of his innovative projects.

Conclusion

Roman Lyman's contributions to the field of drug delivery through his patented invention highlight the importance of innovation in medical technology. His work promises to enhance the effectiveness of treatments and improve patient outcomes.